Literature DB >> 6873246

Experimental ancylostomiasis in chickens: effect of various dose of infective Ancylostoma caninum larvae on their migration and distribution.

R K Agarwal, S M Agarwal.   

Abstract

White leghorn chickens, when infected with repeated doses of Ancylostoma caninum larvae, expel the larvae at a faster rate than when infected with a single dose. This suggests that the initial dose induces some resistance in the host. An initial dose of 1000 and 2000 larvae, followed by a 2nd dose of the same order, induces resistance in the alimentary tract causing the entire larval burden either to migrate to other tissues (organs) or to be expelled in 24 h.

Entities:  

Mesh:

Year:  1983        PMID: 6873246     DOI: 10.1007/bf01990430

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  5 in total

1.  Experimental infection of Ancylostoma caninum in mice. II. Migration and distribution of larvae in tissues after oral infection.

Authors:  M K Bhopale; G N Johri
Journal:  J Helminthol       Date:  1975-09       Impact factor: 2.170

2.  Mast cells and macromolecular leak in intestinal immunological reactions. The influence of sex of rats infected with Nippostrongylus brasiliensis.

Authors:  M Murray; W F Jarrett; F W Jennings
Journal:  Immunology       Date:  1971-07       Impact factor: 7.397

3.  5-hydroxytryptamine in intestinal immunological reactions. Its relationship to mast cell activity and worm expulsion in rats infected with Nippostrongylus brasiliensis.

Authors:  M Murray; H R Miller; J Sanford; W F Jarrett
Journal:  Int Arch Allergy Appl Immunol       Date:  1971

4.  Rejection of worm load through singly and repeatedly sensitized peritoneal exudate cells during experimental ancylostomiasis.

Authors:  V Vardhani; G N Johri
Journal:  Experientia       Date:  1978-01-15

5.  Experimental infection of chickens with Ancylostoma caninum: migration and distribution of larvae in tissues.

Authors:  R K Agarwal; G N Johri
Journal:  J Helminthol       Date:  1980-06       Impact factor: 2.170

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.